Spectrum Pharmaceuticals buy krebskrebs
Start price
23.08.21
/
50%
€2.01
Target price
23.08.22
€3.00
Performance (%)
-34.26%
End price
24.08.22
€1.32
Summary
This prediction ended on 24.08.22 with a price of €1.32. The BUY prediction by krebskrebs for Spectrum Pharmaceuticals performed very badly with a performance of -34.26%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Spectrum Pharmaceuticals | - | - | - |
iShares Core DAX® | 1.175% | -0.931% | 13.543% |
iShares Nasdaq 100 | 1.232% | 9.715% | 34.899% |
iShares Nikkei 225® | 1.563% | 3.040% | 8.943% |
iShares S&P 500 | 0.034% | 5.962% | 27.285% |
Comments by krebskrebs for this prediction
In the thread Spectrum Pharmaceuticals diskutieren
Buy mit Kursziel 3,0
In the thread Trading Spectrum Pharmaceuticals
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten